|
US4722848A
(en)
|
1982-12-08 |
1988-02-02 |
Health Research, Incorporated |
Method for immunizing animals with synthetically modified vaccinia virus
|
|
EP0307434B2
(en)
|
1987-03-18 |
1998-07-29 |
Scotgen Biopharmaceuticals, Inc. |
Altered antibodies
|
|
US5391481A
(en)
|
1990-08-31 |
1995-02-21 |
The Trustees Of Columbia University |
Antibody which is directed against and inhibits collagen binding to a VLA-1 epitope and uses thereof
|
|
GB9022040D0
(en)
|
1990-10-10 |
1990-11-21 |
Biopharm Ltd |
Platelet adhesion inhibitor
|
|
US5851794A
(en)
|
1990-10-22 |
1998-12-22 |
Alfa Laval Ab |
Collagen binding protein as well as its preparation
|
|
US5173414A
(en)
|
1990-10-30 |
1992-12-22 |
Applied Immune Sciences, Inc. |
Production of recombinant adeno-associated virus vectors
|
|
EP0635029A4
(en)
|
1992-04-10 |
1996-01-24 |
Gen Hospital Corp |
MATRIX PROTEIN FROM CARTILAGE AND APPLICATION METHODS.
|
|
US5491130A
(en)
|
1992-11-10 |
1996-02-13 |
The United States Of America As Represented By The Department Of Health And Human Services |
Peptide inhibitors of fibronectin and related collagen-binding proteins
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
US5849589A
(en)
|
1996-03-11 |
1998-12-15 |
Duke University |
Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells
|
|
CA2255669A1
(en)
|
1996-05-16 |
1997-11-20 |
The Texas A & M University System |
Collagen binding protein compositions and methods of use
|
|
US6387663B1
(en)
|
1998-07-31 |
2002-05-14 |
University Of Southern California |
Targeting pharmaceutical agents to injured tissues
|
|
WO2000021989A1
(en)
|
1998-10-09 |
2000-04-20 |
Medimmune, Inc. |
Decorin binding proteins dbp a and b and genes encoding them
|
|
JP2003500011A
(ja)
|
1999-03-15 |
2003-01-07 |
ザ・ジェネラル・ホスピタル・コーポレイション |
シンデスモスおよびその利用法
|
|
US6864235B1
(en)
|
1999-04-01 |
2005-03-08 |
Eva A. Turley |
Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyaluronans
|
|
US6908994B1
(en)
|
1999-05-10 |
2005-06-21 |
The Texas A&M University System |
Collagen-binding proteins from enterococcal bacteria
|
|
WO2000077041A2
(en)
|
1999-06-16 |
2000-12-21 |
The Texas A & M University System |
Peptides from decorin binding protein and their uses
|
|
AU5622800A
(en)
|
1999-06-18 |
2001-01-09 |
Med Immune, Inc. |
Combined decorin binding protein and outer surface protein compositions and methods of use
|
|
NZ519546A
(en)
|
1999-12-15 |
2005-07-29 |
Res Dev Foundation |
Betaglycan as an inhibin receptor and uses thereof
|
|
US6777547B1
(en)
|
2000-01-31 |
2004-08-17 |
Andreas Podbielski |
Collagen-binding proteins from streptococcus pyogenes
|
|
US6517838B1
(en)
|
2000-06-16 |
2003-02-11 |
The Texas A&M University System |
Decorin binding protein essential peptides and methods of use
|
|
AU2001292943A1
(en)
|
2000-09-21 |
2002-04-02 |
The Brigham And Women's Hospital, Inc. |
Prevention and treatment of streptococcal and staphylococcal infection
|
|
EP1411118B1
(en)
|
2001-06-22 |
2008-09-03 |
Chugai Seiyaku Kabushiki Kaisha |
Cell proliferation inhibitors containing anti-glypican-3 antibody
|
|
US8192744B2
(en)
|
2002-08-26 |
2012-06-05 |
Ibcc Holding As |
Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation
|
|
US7488792B2
(en)
|
2002-08-28 |
2009-02-10 |
Burnham Institute For Medical Research |
Collagen-binding molecules that selectively home to tumor vasculature and methods of using same
|
|
GB0406415D0
(en)
|
2004-03-22 |
2004-04-21 |
Inst Of Cancer Res The |
Materials and methods for treatment of cancer
|
|
JP4730304B2
(ja)
|
2004-05-20 |
2011-07-20 |
和光純薬工業株式会社 |
ヒアルロン酸バインディングプロテインを用いたヒアルロン酸の測定方法
|
|
CA2565405A1
(en)
|
2004-06-18 |
2005-12-29 |
F. Hoffmann-La Roche Ag |
Use of protein cbp2 as a marker for colorectal cancer
|
|
CA2544692C
(en)
|
2004-07-09 |
2014-04-01 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-glypican 3 antibody
|
|
WO2006023382A2
(en)
|
2004-08-23 |
2006-03-02 |
Albert Einstein College Of Medicine Of Yeshiva University |
Collagen vi and cancer
|
|
US20090142345A1
(en)
|
2005-03-15 |
2009-06-04 |
Takeda Pharmaceutical Company Limited |
Prophylactic/therapeutic agent for cancer
|
|
CA2610791C
(en)
|
2005-06-08 |
2015-12-01 |
Cangene Corporation |
Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
|
|
CA2612241C
(en)
|
2005-07-01 |
2018-11-06 |
Medarex, Inc. |
Human monoclonal antibodies to programmed death ligand 1 (pd-l1)
|
|
EP1864996A1
(en)
|
2006-06-06 |
2007-12-12 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Peptide associated with rheumatic fever (PARF) and its use as a diagnostic marker.
|
|
HU0600578D0
(en)
|
2006-07-13 |
2006-09-28 |
Szilak Labor Bioinformatikai E |
Nuclear protein transport
|
|
JP5466405B2
(ja)
|
2006-08-08 |
2014-04-09 |
生化学工業株式会社 |
ヒアルロン酸の分子量の測定方法
|
|
DK2178921T3
(en)
|
2007-07-17 |
2016-04-04 |
Squibb & Sons Llc |
Monoclonal antibodies to glypican 3
|
|
KR20110005812A
(ko)
|
2008-03-17 |
2011-01-19 |
고쿠리츠 다이가쿠 호징 미야자키 다이가쿠 |
항-글리피칸-3 항체를 사용하여 간암 세포를 검출하는 방법
|
|
US20090297479A1
(en)
|
2008-03-28 |
2009-12-03 |
Kiyoshi Ariizumi |
Dc-hil conjugates for treatment of t-cell disorders
|
|
HUE029925T2
(en)
|
2008-04-02 |
2017-04-28 |
Macrogenics Inc |
HER2 / neu-specific antibodies and methods using them
|
|
US8034630B2
(en)
|
2008-04-15 |
2011-10-11 |
Wako Pure Chemical Industries, Ltd. |
Protein capable of binding to hyaluronic acid, and method for measurement of hyaluronic acid using the same
|
|
WO2010033866A2
(en)
|
2008-09-19 |
2010-03-25 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Monoclonal antibodies for cspg4 for the diagnosis and treatment of basal breast carcinoma
|
|
GB0818273D0
(en)
|
2008-10-06 |
2008-11-12 |
Cambridge Entpr Ltd |
Modulation of cellular activity and differentiation
|
|
KR101105428B1
(ko)
|
2009-02-12 |
2012-01-17 |
경북대학교 산학협력단 |
글리피칸-3 단백질과 특이적으로 결합하는 펩타이드
|
|
WO2010129547A1
(en)
|
2009-05-04 |
2010-11-11 |
Purdue Research Foundation |
Collagen-binding synthetic peptidoglycans for wound healing
|
|
US8906649B2
(en)
|
2010-09-27 |
2014-12-09 |
Janssen Biotech, Inc. |
Antibodies binding human collagen II
|
|
SG10201508401TA
(en)
*
|
2010-10-11 |
2015-11-27 |
Abbvie Bahamas Ltd |
Processes for purification of proteins
|
|
US9260492B2
(en)
|
2010-11-15 |
2016-02-16 |
Pieris Ag |
Muteins of human lipocalin 2 with affinity for glypican-3 (GPC-3)
|
|
HUE029139T2
(hu)
*
|
2011-02-10 |
2017-02-28 |
Roche Glycart Ag |
Mutáns interleukin-2 polipeptidek
|
|
ES2692268T5
(en)
|
2011-03-29 |
2025-02-26 |
Roche Glycart Ag |
Antibody fc variants
|
|
WO2012145469A1
(en)
|
2011-04-19 |
2012-10-26 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
|
EP2714718B1
(en)
|
2011-05-24 |
2017-01-11 |
Symic IP, LLC |
Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
|
|
US20140322216A1
(en)
|
2011-11-08 |
2014-10-30 |
The Trustees Of The University Of Pennsylvania |
Glypican-3-specific antibody and uses thereof
|
|
US9795686B2
(en)
|
2012-01-19 |
2017-10-24 |
The Johns Hopkins University |
Biomaterials comprising hyaluronic acid binding peptides and bifunctional biopolymer molecules for hyaluronic acid retention and tissue engineering applications
|
|
WO2013163766A1
(en)
|
2012-05-04 |
2013-11-07 |
Cangene Corporation |
ANTIMICROBIAL COMPOSITIONS COMPRISING A HYALURONIC ACID BINDING PEPTIDE AND A β-LACTAM ANTIBIOTIC
|
|
US9522940B2
(en)
|
2012-05-23 |
2016-12-20 |
Pieris Pharmaceuticals Gmbh |
Lipocalin muteins with binding-affinity for glypican-3 (GPC-3) and use of lipocalin muteins for target-specific delivery to cells expressing GPC-3
|
|
US9409994B2
(en)
|
2012-06-01 |
2016-08-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
|
US10093745B2
(en)
|
2013-05-29 |
2018-10-09 |
The Regents Of The University Of California |
Anti-CSPG4 fusions with interferon for the treatment of malignancy
|
|
US20160032007A1
(en)
|
2014-04-28 |
2016-02-04 |
Duke University |
Human Antibody Fragments Against Chondroitin Sulfate Proteoglycan 4 (CSPG4)
|
|
WO2015197593A1
(en)
|
2014-06-27 |
2015-12-30 |
Innate Pharma |
MULTISPECIFIC NKp46 BINDING PROTEINS
|
|
WO2016007919A2
(en)
|
2014-07-11 |
2016-01-14 |
Regents Of The University Of Minnesota |
Antibody fragments for detecting cancer and methods of use
|
|
MA40764A
(fr)
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
|
US11091547B2
(en)
|
2014-11-12 |
2021-08-17 |
Memorial Sloan Kettering Cancer Center |
Anti-chondroitin sulfate proteoglycan 4 antibodies and uses thereof
|
|
JP6920207B2
(ja)
|
2015-03-20 |
2021-08-18 |
オルブセン セラピューティクス リミテッド |
シンデカン−２のモジュレーターとその使用
|
|
US10881711B2
(en)
|
2015-04-06 |
2021-01-05 |
The General Hospital Corporation |
Anti-CSPG4 reagents and methods of treating cancer
|
|
KR20180033502A
(ko)
*
|
2015-06-12 |
2018-04-03 |
알렉터 엘엘씨 |
항-cd33 항체 및 그의 사용 방법
|
|
JP6762485B2
(ja)
|
2015-06-24 |
2020-09-30 |
学校法人慶應義塾 |
抗グリピカン−１−免疫抗原受容体
|
|
EP3349770A1
(en)
|
2015-09-14 |
2018-07-25 |
Regents of the University of Minnesota |
Nk cells exhibiting an adaptive phenotype and methods for preparing and for using
|
|
EP3353198B1
(en)
|
2015-09-23 |
2020-06-17 |
Bristol-Myers Squibb Company |
Glypican-3binding fibronectin based scafflold molecules
|
|
EP3359168A4
(en)
|
2015-10-06 |
2019-08-07 |
Regents of the University of Minnesota |
THERAPEUTIC COMPOUNDS AND METHOD
|
|
KR101796688B1
(ko)
|
2015-10-29 |
2017-12-01 |
재단법인 목암생명과학연구소 |
신규 항-글리피칸 3 항체 및 이를 포함하는 약학적 조성물
|
|
US11066479B2
(en)
|
2016-08-02 |
2021-07-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof
|
|
KR102050463B1
(ko)
*
|
2016-08-10 |
2019-11-29 |
아주대학교산학협력단 |
항체 중쇄불변부위 이종이중체 (heterodimeric Fc)에 융합된 사이토카인 (heterodimeric Fc-fused cytokine) 및 이를 포함하는 약제학적 조성물
|
|
BR112019007281A2
(pt)
*
|
2016-10-14 |
2019-07-09 |
Xencor Inc |
proteína heterodimérica, composições de ácido nucleico e de vetor de expressão, vetor de expressão, célula hospedeira, e, métodos para produzir proteína heterodimérica e para tratar câncer em um paciente
|
|
CN110831634B
(zh)
|
2017-03-08 |
2024-07-02 |
密歇根大学董事会 |
磷脂酰肌醇蛋白聚糖-3肽试剂和方法
|
|
EP3615573A4
(en)
|
2017-04-26 |
2021-01-20 |
Mitsubishi Tanabe Pharma Corporation |
SYNDECAN-1 (CD138) BINDING AGENTS AND THEIR USES
|
|
US20200308299A1
(en)
|
2017-04-28 |
2020-10-01 |
National University Corporation Kochi University |
Anti-gpc-1 antibody
|
|
US11547957B2
(en)
*
|
2017-05-11 |
2023-01-10 |
Emd Millipore Corporation |
Method of maintaining narrow residence time distributions in continuous flow systems
|
|
WO2018237159A1
(en)
*
|
2017-06-21 |
2018-12-27 |
Cephalon, Inc. |
Cation exchange chromatography wash buffer
|
|
EP3925976A1
(en)
*
|
2017-09-07 |
2021-12-22 |
Dragonfly Therapeutics, Inc. |
Proteins binding nkg2d, cd16 and a tumor-associated antigen
|
|
SG11202007579TA
(en)
|
2018-02-08 |
2020-09-29 |
Dragonfly Therapeutics Inc |
Combination therapy of cancer involving multi-specific binding proteins that activate natural killer cells
|
|
SG11202103192RA
(en)
*
|
2018-10-03 |
2021-04-29 |
Xencor Inc |
Il-12 heterodimeric fc-fusion proteins
|
|
CA3117212A1
(en)
*
|
2018-10-23 |
2020-04-30 |
Dragonfly Therapeutics, Inc. |
Heterodimeric fc-fused proteins
|